Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Top Cited Papers
- 1 September 2006
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 6 (9) , 589-601
- https://doi.org/10.1016/s1473-3099(06)70580-1
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibioticClinical Microbiology & Infection, 2005
- Colistin-associated Acute Renal Failure: RevisitedSouthern Medical Journal, 2005
- Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial PeptidesInfection and Immunity, 2004
- Use of Intravenous Polymyxin B During Continuous Venovenous HemodialysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii MeningitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosisThorax, 1997
- Characterization of the lipopolysaccharide from the polymyxin‐resistant pmrA mutants of Salmonella typhimuriumFEBS Letters, 1981
- Isolation and genetic characterization of polymyxin-resistant mutants ofSalmonellaFEMS Microbiology Letters, 1978